Title : Semi-Mechanistic Pharmacokinetic-Pharmacodynamic Model of Camostat Mesylate-Predicted Efficacy against SARS-CoV-2 in COVID-19.

Pub. Date : 2022 Apr 27

PMID : 35412356






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 For camostat 200 mg dosed four times daily, 90% inhibition of TMPRSS2 is predicted to occur but with only about 40% viral entry inhibition. camostat transmembrane serine protease 2 Homo sapiens